Perinephric myxoid pseudotumor of fat: a multimodality imaging case series.
Justin LeeKevin G KingShefali ChopraPhillip M ChengPublished in: Abdominal radiology (New York) (2022)
Perinephric myxoid pseudotumor of fat (PMPF) is an unusual clinical entity with few prior imaging case reports. We report a multimodality imaging case series of PMPF, consisting of four cases seen in our department with both imaging studies and histopathologic confirmation. Three of the four patients had a history of advanced non-neoplastic renal disease. The perirenal masses in these cases varied in size and appearance. Some lesions resembled cysts or contained macroscopic fat. Enhancement was equivocal on CT, but prominent in one case on MRI and in another on contrast-enhanced ultrasound. Although not known to be malignant, PMPF may be confused for a cyst, liposarcoma, or hypovascular solid neoplasm on imaging. The dominant mass was resected in two cases because of concern for malignancy, while percutaneous CT-guided biopsy was performed in the other two. Mouse double minute 2 (MDM2) gene amplification by fluorescence in situ hybridization (FISH) was negative in all four cases, excluding well-differentiated liposarcoma. Radiologists should be familiar with PMPF to provide appropriate guidance on clinical management.
Keyphrases
- high resolution
- adipose tissue
- computed tomography
- contrast enhanced
- end stage renal disease
- chronic kidney disease
- contrast enhanced ultrasound
- prognostic factors
- minimally invasive
- fatty acid
- artificial intelligence
- case report
- low grade
- image quality
- genome wide
- dna methylation
- high grade
- peritoneal dialysis
- dual energy
- radiofrequency ablation
- label free
- genome wide identification